Operates as a biopharmaceutical company, which focuses on the treatment of obesity
Sector:
Health Technology
Industry:
Biotechnology
Employees:
Frequently Asked Questions
What is Market Cap of Orexigen Therapeutics, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Orexigen Therapeutics, Inc. market cap is $234,000.00.
What is the 52-week high for Orexigen Therapeutics, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Orexigen Therapeutics, Inc. 52 week high is $2.39 as of October 24, 2025.
What is the 52-week low for Orexigen Therapeutics, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Orexigen Therapeutics, Inc. 52 week low is $0.015 as of October 24, 2025.
What is Orexigen Therapeutics, Inc. stock price today?
Orexigen Therapeutics, Inc. stock price today is $0.023.
What was Orexigen Therapeutics, Inc. stock price yesterday?
Orexigen Therapeutics, Inc. stock price yesterday was $0.015.
What is the PE ratio of Orexigen Therapeutics, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Orexigen Therapeutics, Inc.’s P/E ratio is None.
What is the Price-to-Book ratio of Orexigen Therapeutics, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Orexigen Therapeutics, Inc. P/B ratio is -0.0038.
What is Orexigen Therapeutics, Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Orexigen Therapeutics, Inc.'s EBITDA is -0.92.
What is the 50-day moving average of Orexigen Therapeutics, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Orexigen Therapeutics, Inc. 50-day moving average is $0.0328.
How many employess does Orexigen Therapeutics, Inc. has?
